First Tracks Biotherapeutics, Inc. · NASDAQ:TRAX
Chen Yu reported a 8.30% stake in First Tracks Biotherapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Chen Yu reported a 8.30% stake in First Tracks Biotherapeutics, Inc., 2,895,304 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 8.30%
- Shares
- 2,895,304
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| TCG Crossover GP II, LLC | 4.10% | 1,447,652 |
| TCG Crossover Fund II, L.P. | 4.10% | 1,447,652 |
| TCG Crossover GP III, LLC | 4.10% | 1,447,652 |
| TCG Crossover Fund III, L.P. | 4.10% | 1,447,652 |
| Chen Yu | 8.30% | 2,895,304 |
Source
Related
- First Tracks Biotherapeutics, Inc.
- TCG Crossover GP II, LLC
- First Tracks Biotherapeutics, Inc. shareholders
- Form 4 · Orwin John A · Sep 17, 2026
- Form 4 · Ware J. Anthony · Sep 4, 2026
- Schedule 13G · Sirenia Capital Management LP · Aug 14, 2026
- Schedule 13G · Affinity Asset Advisors, LLC · Aug 13, 2026
- Schedule 13G · FMR LLC · Aug 6, 2026